drugset / Trial / NCT01689506

Fluid Resuscitation in Patients Suffering From Burns Injury

NCT01689506

Phase 4 Terminated 11 enrolled Fresenius Kabi
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical study compares two fluid resuscitation treatments in patients suffering from burns injury. The treatments are Volulyte® and Human Serum Albumin (HSA) which will be administered as infusion solutions. It will be evaluated whether Volulyte® is effective and safe, and provides any benefit.

Timeline

Start
2012-12
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Human serum albumin Protein / enzyme biologic 5 % Intravenous
Subject Volulyte Other / unclassified 6 % Intravenous
Subject Volulyte Other / unclassified 50 unknown Intravenous

Indications

No indication recorded.